Il Dong Pharmaceutical Co Ltd Total Liabilities
Il Dong Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Il Dong Pharmaceutical Co Ltd (249420) has total liabilities worth ₩347.04 Billion KRW (≈ $235.18 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 249420 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Il Dong Pharmaceutical Co Ltd (2016–2024)
Total liabilities of Il Dong Pharmaceutical Co Ltd from 2016 to 2024. This chart illustrates how Il Dong Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Il Dong Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Il Dong Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Il Dong Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mahamaya Steel Industries Limited
NSE:MAHASTEEL
|
India | Rs-1.59 Billion |
|
Columbus Circle Capital Corp I Class A Ordinary Shares
NASDAQ:CCCM
|
USA | $676.71K |
|
DYNAM JAPAN HOLDINGS Co. Ltd
F:2DJ
|
Germany | €227.93 Billion |
|
Anika Therapeutics Inc
NASDAQ:ANIK
|
USA | $46.19 Million |
|
Zhejiang Dilong New Material Co Ltd
SHE:002247
|
China | CN¥281.35 Million |
|
Beijing Piesat Information Technology Co Ltd
SHG:688066
|
China | CN¥3.81 Billion |
|
Karmarts Public Company Limited
BK:KAMART
|
Thailand | ฿1.49 Billion |
|
EnviTec Biogas AG
XETRA:ETG
|
Germany | €237.48 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Il Dong Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 249420 current and non-current assets.
Liquidity & Leverage Metrics
Il Dong Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Il Dong Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.60 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Il Dong Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Il Dong Pharmaceutical Co Ltd (2016–2024)
The table below shows the annual total liabilities of Il Dong Pharmaceutical Co Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩429.99 Billion ≈ $291.39 Million |
-1.60% |
| 2023-12-31 | ₩437.00 Billion ≈ $296.15 Million |
-4.50% |
| 2022-12-31 | ₩457.59 Billion ≈ $310.10 Million |
-16.56% |
| 2021-12-31 | ₩548.39 Billion ≈ $371.63 Million |
+56.36% |
| 2020-12-31 | ₩350.73 Billion ≈ $237.68 Million |
-2.53% |
| 2019-12-31 | ₩359.83 Billion ≈ $243.85 Million |
+25.01% |
| 2018-12-31 | ₩287.84 Billion ≈ $195.07 Million |
+2.97% |
| 2017-12-31 | ₩279.55 Billion ≈ $189.45 Million |
-0.85% |
| 2016-12-31 | ₩281.94 Billion ≈ $191.07 Million |
-- |
About Il Dong Pharmaceutical Co Ltd
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central n… Read more